Recursion Pharmaceuticals Inc Clas (RXRX)
Deferred Revenue
$27.59M
Quarterly · Period ending: · USD
RXRX Deferred Revenue
Latest reported$27.59Mperiod ending
Latest reported$27.59Mperiod ending
RXRX Quarterly Deferred Revenue ($0.00 → $27.59M)
Quarterly deferred revenue
High-resolution chart · PNG
RXRX deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 27,586,000 | |
| 32,794,000 | |
| 37,605,000 | |
| 47,364,000 | |
| 39,690,000 | |
| 39,651,000 | |
| 61,767,000 | |
| 49,579,000 | |
| 32,204,000 | |
| 36,618,000 | |
| 36,426,000 | |
| 43,997,000 | |
| 73,105,000 | |
| 57,761,000 | |
| 56,726,000 | |
| 46,753,000 | |
| 63,781,000 | |
| 54,247,000 | |
| 10,000,000 | |
| 10,000,000 | |
| 10,000,000 | |
| 10,000,000 | |
| 10,000,000 | |
| 0 |